Yoshito Komatsu Selected Research

Yoshito Komatsu Research Topics

Disease

66	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2005
44	Neoplasms (Cancer) 01/2022 - 06/2004
36	Stomach Neoplasms (Stomach Cancer) 06/2022 - 06/2004
17	Neutropenia 12/2021 - 06/2006
12	Disease Progression 01/2022 - 01/2010
11	Adenocarcinoma 10/2021 - 09/2012
10	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2008
9	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022 - 04/2009
6	Nausea 08/2020 - 06/2006
5	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2013
5	Vomiting 08/2020 - 01/2012
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 06/2022 - 02/2005
4	Diarrhea 07/2021 - 04/2010
4	Hypertension (High Blood Pressure) 06/2015 - 04/2010
3	Microsatellite Instability 01/2022 - 02/2021
3	Hypertriglyceridemia 12/2021 - 01/2021
3	Febrile Neutropenia 12/2021 - 01/2006
3	Hyponatremia 01/2019 - 04/2010
3	Fatigue 01/2018 - 04/2010
3	Carcinoma (Carcinomatosis) 07/2011 - 06/2004
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 06/2022 - 01/2021
2	Esophageal Squamous Cell Carcinoma 03/2022 - 11/2011
2	Thrombosis (Thrombus) 01/2022 - 04/2011
2	Pain (Aches) 01/2022 - 07/2021
2	Edema (Dropsy) 01/2022 - 06/2014
2	Adenocarcinoma of Lung 07/2021 - 12/2016
2	Hypocalcemia 01/2021 - 01/2021
2	Leukopenia 08/2020 - 05/2015
2	Anemia 01/2019 - 04/2010
2	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2015
2	Sigmoid Neoplasms 08/2011 - 03/2010
1	Dysgeusia (Parageusia) 06/2022
1	Pathologic Complete Response 01/2022

Drug/Important Bio-Agent (IBA)

34	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 06/2004
23	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 01/2010
21	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 11/2008
16	Bevacizumab (Avastin)FDA Link 12/2021 - 10/2010
13	Leucovorin (Folinic Acid)FDA Link 01/2022 - 09/2010
10	trifluridine tipiracil drug combinationIBA 07/2021 - 10/2012
9	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 04/2009
8	Biomarkers (Surrogate Marker)IBA 03/2022 - 06/2014
8	Capecitabine (Xeloda)FDA Link 12/2021 - 10/2010
8	Cisplatin (Platino)FDA LinkGeneric 05/2021 - 01/2006
8	regorafenibIBA 04/2020 - 06/2015
7	Gemcitabine FDA Link 01/2022 - 02/2011
7	Sunitinib (Sutent)FDA Link 11/2015 - 04/2009
6	Pharmaceutical PreparationsIBA 06/2022 - 06/2006
6	RamucirumabIBA 01/2022 - 10/2014
6	TegafurIBA 12/2021 - 07/2010
6	Cetuximab (Erbitux)FDA Link 05/2021 - 11/2008
5	Circulating Tumor DNAIBA 01/2022 - 01/2017
5	130-nm albumin-bound paclitaxelIBA 06/2021 - 06/2017
5	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 01/2017
5	Paclitaxel (Taxol)FDA LinkGeneric 12/2017 - 01/2006
4	pembrolizumabIBA 01/2022 - 01/2020
4	Formaldehyde (Formol)FDA Link 01/2022 - 01/2015
4	ParaffinIBA 01/2022 - 01/2015
4	Trastuzumab (Herceptin)FDA Link 01/2022 - 01/2020
4	human ERBB2 proteinIBA 01/2022 - 01/2015
4	Panitumumab (Vectibix)FDA Link 07/2021 - 01/2015
4	ErbB Receptors (EGF Receptor)IBA 07/2021 - 01/2015
4	PlatinumIBA 01/2021 - 10/2014
4	CalciumIBA 01/2021 - 01/2010
4	Monoclonal AntibodiesIBA 01/2021 - 03/2004
4	Proteins (Proteins, Gene)FDA Link 11/2019 - 04/2009
3	Immune Checkpoint InhibitorsIBA 01/2022 - 10/2020
3	NivolumabIBA 01/2022 - 01/2019
3	AntiemeticsIBA 01/2022 - 06/2006
3	PotassiumIBA 12/2021 - 07/2010
3	Oxonic AcidIBA 12/2021 - 07/2010
3	gimeracilIBA 12/2021 - 07/2010
3	Albumin-Bound Paclitaxel FDA Link 06/2021 - 06/2017
3	S-1 plus cisplatinIBA 05/2021 - 01/2016
3	Dexamethasone (Maxidex)FDA LinkGeneric 12/2019 - 07/2015
3	afliberceptIBA 11/2019 - 01/2014
2	trastuzumab deruxtecanIBA 06/2022 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2018
2	folfirinoxIBA 01/2022 - 06/2017
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2022 - 10/2014
2	SuspensionsIBA 06/2021 - 01/2021
2	Vitamin D FDA LinkGeneric 01/2021 - 01/2021
2	Denosumab FDA Link 01/2021 - 01/2021
2	Palonosetron (Aloxi)FDA Link 12/2019 - 07/2015
2	Everolimus FDA Link 09/2018 - 04/2010
2	AnthracyclinesIBA 07/2015 - 10/2014
2	Levoleucovorin FDA Link 08/2012 - 01/2010
2	XELOXIBA 04/2011 - 10/2010
1	ZincIBA 06/2022
1	Zinc Acetate FDA Link 06/2022
1	polaprezinc (Z 103)IBA 06/2022
1	LigandsIBA 01/2022

Therapy/Procedure

55	Drug Therapy (Chemotherapy) 06/2022 - 06/2004
48	Therapeutics 06/2022 - 10/2004
7	Combination Drug Therapy (Combination Chemotherapy) 01/2022 - 01/2008
3	Precision Medicine 01/2022 - 09/2018
2	Chemoradiotherapy 01/2022 - 11/2011
2	Drug Tapering 06/2021 - 12/2020
2	Adjuvant Chemotherapy 12/2016 - 05/2007
2	Radiotherapy 12/2013 - 04/2010